BM
Boehm Marcus Director
Board M
US US · SEC (Form 4)
€130,829
▲ Purchases (12 ops.)
Explore the detailed record of transactions filed by Boehm Marcus, Director. Officer active across 2 companies, notably Vyant Bio, Inc.. In total, 20 disclosures have been recorded. Total volume traded: €131k. The latest transaction was disclosed on 18 January 2022 — Attribution. Regulator: SEC (Form 4). All data is free.
Declarations 20 total
7,281 shares
Common Stock, $0.0001 par value
SEC:0001493152-22-010472:0 · 18 Apr 2022
43,478 shares
Common Stock, $0.0001 par value
SEC:0001493152-22-008830:0 · 30 Mar 2022
€6,573 5,725 shares @ €1.1481 9.1% of flow
Common Stock, $0.0001 par value
SEC:0001493152-22-001787 · 18 Jan 2022
€6,573 5,725 shares @ €1.1481 4.6% of flow
Common Stock, $0.0001 par value
SEC:0001493152-22-001787:0 · 18 Jan 2022
€7,475 5,000 shares @ €1.4949 10.4% of flow
Common Stock, $0.0001 par value
SEC:0001493152-21-030665 · 6 Dec 2021
Ideal exit: 2 Sept 2022 (T+270) €7,475 5,000 shares @ €1.4949 5.2% of flow
Common Stock, $0.0001 par value
SEC:0001493152-21-030665:0 · 6 Dec 2021
Ideal exit: 2 Sept 2022 (T+270) €9,052 5,000 shares @ €1.8103 12.6% of flow
Common Stock, $0.0001 par value
SEC:0001493152-21-026627 · 27 Oct 2021
Ideal exit: 24 Jul 2022 (T+270) €9,052 5,000 shares @ €1.8103 6.3% of flow
Common Stock, $0.0001 par value
SEC:0001493152-21-026627:0 · 27 Oct 2021
Ideal exit: 24 Jul 2022 (T+270) €10,516 5,000 shares @ €2.1032 14.6% of flow
Common Stock, $0.0001 par value
SEC:0001493152-21-024156 · 29 Sept 2021
Ideal exit: 26 Jun 2022 (T+270) €10,516 5,000 shares @ €2.1032 7.3% of flow
Common Stock, $0.0001 par value
SEC:0001493152-21-024156:0 · 29 Sept 2021
Ideal exit: 26 Jun 2022 (T+270) €10,937 5,000 shares @ €2.1875 15.2% of flow
Common Stock, $0.0001 par value
SEC:0001493152-21-021298 · 25 Aug 2021
Ideal exit: 22 May 2022 (T+270) €10,937 5,000 shares @ €2.1875 7.6% of flow
Common Stock, $0.0001 par value
SEC:0001493152-21-021298:0 · 25 Aug 2021
Ideal exit: 22 May 2022 (T+270) €12,345 5,000 shares @ €2.4689 17.1% of flow
Common Stock, $0.0001 par value
SEC:0001493152-21-018019 · 28 Jul 2021
Ideal exit: 24 Apr 2022 (T+270) €12,345 5,000 shares @ €2.4689 8.6% of flow
Common Stock, $0.0001 par value
SEC:0001493152-21-018019:0 · 28 Jul 2021
Ideal exit: 24 Apr 2022 (T+270) 078,263 shares 0
Common Stock, $0.0001 par value
SEC:0001493152-21-015870 · 5 May 2021
93,786 shares
Common Stock, $0.0001 par value
SEC:0001493152-21-015911 · 30 Mar 2021
078,263 shares 0
Common Stock, $0.0001 par value
SEC:0001493152-21-015870:0 · 5 May 2021
93,786 shares
Common Stock, $0.0001 par value
SEC:0001493152-21-015911:0 · 30 Mar 2021
€15,090 5,000 shares @ €3.0181 21.0% of flow
Common Stock, $0.0001 par value
SEC:0001493152-21-013359 · 28 May 2021
Ideal exit: 22 Feb 2022 (T+270) €15,090 5,000 shares @ €3.0181 10.5% of flow
Common Stock, $0.0001 par value
SEC:0001493152-21-013359:0 · 28 May 2021
Ideal exit: 22 Feb 2022 (T+270) About Boehm Marcus Marcus Boehm is an executive at Vyant Bio, Inc.